Clinical Risk Factors for Uterine Cervical Elongation among Women with Pelvic Organ Prolapse.
cervical elongation
hysteropexy
pelvic organ prolapse
predictor
risk factor
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
02 09 2021
02 09 2021
Historique:
received:
21
06
2021
revised:
29
08
2021
accepted:
31
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Cervical elongation is commonly associated with pelvic organ prolapse (POP). It was an identified risk for recurrent prolapse after hysteropexy, requiring additional surgeries. The aim of the study is to investigate the risk factors for uterine cervical elongation among women with POP. In this single-center retrospective cohort study, women who underwent vaginal total hysterectomy for POP between 2014 and 2016 were collected. The cervical and total uterine lengths were measured by pathologists, while the ratio of cervical length to total uterine length were calculated. The cervical elongation is defined as corpus/cervix ratio ≤ 1.5. A total of 133 patients were enrolled in this study. Among these patients, 43 women had cervical elongation and 90 women had normal length of uterine cervix. We found that age > 65 years old (67.4% vs. 42.2%, The patient age > 65 years old, the total vaginal length of POP-Q system ≥ 9.5 cm, uterine weight < 51 g, and POPDI-6 ≥ 12 are independent risk factors of cervical elongation in women with POP. For women scheduled for pelvic reconstructive hysteropexy, concomitant cervical amputation should be considered.
Sections du résumé
BACKGROUND
Cervical elongation is commonly associated with pelvic organ prolapse (POP). It was an identified risk for recurrent prolapse after hysteropexy, requiring additional surgeries. The aim of the study is to investigate the risk factors for uterine cervical elongation among women with POP.
METHODS
In this single-center retrospective cohort study, women who underwent vaginal total hysterectomy for POP between 2014 and 2016 were collected. The cervical and total uterine lengths were measured by pathologists, while the ratio of cervical length to total uterine length were calculated. The cervical elongation is defined as corpus/cervix ratio ≤ 1.5.
RESULTS
A total of 133 patients were enrolled in this study. Among these patients, 43 women had cervical elongation and 90 women had normal length of uterine cervix. We found that age > 65 years old (67.4% vs. 42.2%,
CONCLUSION
The patient age > 65 years old, the total vaginal length of POP-Q system ≥ 9.5 cm, uterine weight < 51 g, and POPDI-6 ≥ 12 are independent risk factors of cervical elongation in women with POP. For women scheduled for pelvic reconstructive hysteropexy, concomitant cervical amputation should be considered.
Identifiants
pubmed: 34501846
pii: ijerph18179255
doi: 10.3390/ijerph18179255
pmc: PMC8431083
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Obstet Gynecol. 2001 Dec;185(6):1388-95
pubmed: 11744914
Sci Rep. 2020 Apr 20;10(1):6615
pubmed: 32313187
Am J Obstet Gynecol. 2018 Aug;219(2):129-146.e2
pubmed: 29353031
J Obstet Gynaecol Can. 2017 Apr;39(4):223-228
pubmed: 28413041
Int Urogynecol J. 2010 Aug;21(8):995-1000
pubmed: 20333504
J Obstet Gynaecol Can. 2016 Mar;38(3):265-9
pubmed: 27106197
Int Urogynecol J. 2014 Apr;25(4):457-64
pubmed: 24170226
Gynecol Obstet Invest. 1996;42(1):35-8
pubmed: 8840176
Obstet Gynecol. 1997 Apr;89(4):501-6
pubmed: 9083302
Sci Rep. 2018 Jun 21;8(1):9438
pubmed: 29930249
Neurourol Urodyn. 2000;19(3):213-20
pubmed: 10797578
Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):224-7
pubmed: 22326614
Int Urogynecol J. 2013 Sep;24(9):1579-80
pubmed: 23052629
Int Urogynecol J. 2012 Jul;23(7):865-72
pubmed: 22270728
Curr Opin Obstet Gynecol. 2016 Oct;28(5):420-9
pubmed: 27517338
Int Urogynecol J. 2014 Jun;25(6):851-4
pubmed: 24297063
J Obstet Gynaecol Can. 2015 Feb;37(2):129-137
pubmed: 25767945
Int Urogynecol J. 2016 Mar;27(3):491-3
pubmed: 26476819
Ultrasound Obstet Gynecol. 1996 Jan;7(1):38-42
pubmed: 8932630
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
pubmed: 8694033
Int Urogynecol J. 2012 Aug;23(8):1095-103
pubmed: 22527546
Am J Obstet Gynecol. 2005 Mar;192(3):795-806
pubmed: 15746674
Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:94-97
pubmed: 30144728
Int Urogynecol J. 2019 Aug;30(8):1279-1282
pubmed: 30357469
Eur J Obstet Gynecol Reprod Biol. 2016 May;200:40-4
pubmed: 26967345
J Urol. 1999 Feb;161(2):581-6
pubmed: 9915453
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Sep;20(9):1037-45
pubmed: 19444368